F8 and autoimmune hemolytic anemia: Plasma-derived porcine FVIII concentrate was successfully used in the past to manage AHA, in particular because FVIII autoantibodies often have low cross-reactivity with porcine FVIII; however, it is no longer commercially available, but a recombinant porcine B-domain-depleted FVIII molecule is under development [10].